Caregivers Press For Experimental Alzheimer's Drug

A medical study published in Science finds that an FDA-approved skin cancer drug can reduce Alzheimer's-like symptoms in mice. It is unclear if the drug, marketed as Targretin, will have the same effect on humans. Some researchers want to begin testing the drug for its efficacy in treating Alzheimer's patients.